| Tretinoin | Approved Investigational Nutraceutical | MRPL23 | 6150 |
downregulated | Tretinoin results in decreased expression of MRPL23 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL24 | 79590 |
downregulated | Tretinoin results in decreased expression of MRPL24 mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL28 | 10573 |
upregulated | Tretinoin results in increased expression of MRPL28 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL3 | 11222 |
downregulated | Tretinoin results in decreased expression of MRPL3 mRNA | 3q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL42 | 28977 |
downregulated | Tretinoin results in decreased expression of MRPL42 mRNA | 12q22 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL50 | 54534 |
downregulated | Tretinoin results in decreased expression of MRPL50 mRNA | 9q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL52 | 122704 |
downregulated | Tretinoin results in decreased expression of MRPL52 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPS10 | 55173 |
downregulated | Tretinoin results in decreased expression of MRPS10 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPS12 | 6183 |
downregulated | Tretinoin results in decreased expression of MRPS12 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPS2 | 51116 |
downregulated | Tretinoin results in decreased expression of MRPS2 mRNA | 9q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MRRF | 92399 |
downregulated | Tretinoin results in decreased expression of MRRF mRNA | 9q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MSH6 | 2956 |
downregulated | Tretinoin results in decreased expression of MSH6 mRNA | 2p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MSI2 | 124540 |
downregulated | Tretinoin results in decreased expression of MSI2 mRNA | 17q22 | |
| Tretinoin | Approved Investigational Nutraceutical | MSMO1 | 6307 |
downregulated | Tretinoin results in decreased expression of MSMO1 mRNA | 4q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MST1L | 11223 |
upregulated | Tretinoin results in increased expression of MST1L mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | MSX1 | 4487 |
upregulated | Tretinoin results in increased expression of MSX1 mRNA | 4p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MSX2 | 4488 |
downregulated | Tretinoin results in decreased expression of MSX2 mRNA | 5q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MSX2 | 4488 |
upregulated | Tretinoin results in increased expression of MSX2 mRNA | 5q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MSX2P1 | 55545 |
upregulated | Tretinoin results in increased expression of MSX2P1 mRNA | 17q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MT1X | 4501 |
downregulated | Tretinoin results in decreased expression of MT1X mRNA | 16q13 | |
| Tretinoin | Approved Investigational Nutraceutical | MTA1 | 9112 |
downregulated | Tretinoin results in decreased expression of MTA1 mRNA | 14q32.33 | |
| Tretinoin | Approved Investigational Nutraceutical | MTCL1 | 23255 |
downregulated | Tretinoin results in decreased expression of MTCL1 mRNA | 18p11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | MTFR1 | 9650 |
downregulated | Tretinoin results in decreased expression of MTFR1 mRNA | 8q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MTHFD1L | 25902 |
downregulated | Tretinoin results in decreased expression of MTHFD1L mRNA | 6q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MTHFD2 | 10797 |
downregulated | Tretinoin results in decreased expression of MTHFD2 mRNA | 2p13.1 | |